News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Conference News ESC 2020 Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care Shelley Wood August 30, 2020
News Conference News HRS 2020 PRECEPT Provides Support for Ablation of Symptomatic, Persistent A-fib Todd Neale May 15, 2020
News Daily News AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events Yael L. Maxwell March 13, 2020
News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Daily News Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF Caitlin E. Cox March 02, 2020
News Features Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019 Caitlin E. Cox December 17, 2019
News Daily News Long-term Watchman Data Reassure: CAP and CAP2 Registries Michael O'Riordan December 02, 2019
News Daily News Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis Michael O'Riordan October 29, 2019
News Daily News New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR Todd Neale October 18, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Daily News No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study Michael O'Riordan August 19, 2019
News Features Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics Marcus A. Banks August 15, 2019